Skip to main content
Download PDF

Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate

BMC Oral Health volume 23, Article number: 111 (2023) Cite this article

Abstract

Background

Droplets and aerosols produced during dental procedures are a risk factor for microbial and viral transmission. Unlike sodium hypochlorite, hypochlorous acid (HOCl) is nontoxic to tissues but still exhibits broad microbicidal effect. HOCl solution may be applicable as a supplement to water and/or mouthwash. This study aims to evaluate the effectiveness of HOCl solution on common human oral pathogens and a SARS-CoV-2 surrogate MHV A59 virus, considering the dental practice environment.

Methods

HOCl was generated by electrolysis of 3% hydrochloric acid. The effect of HOCl on human oral pathogens, Fusobacterium nucleatum, Prevotella intermedia, Streptococcus intermedius, Parvimonas micra, and MHV A59 virus was studied from four perspectives: concentration; volume; presence of saliva; and storage. HOCl solution in different conditions was utilized in bactericidal and virucidal assays, and the minimum inhibitory volume ratio that is required to completely inhibit the pathogens was determined.

Results

In the absence of saliva, the minimum inhibitory volume ratio of freshly prepared HOCl solution (45–60 ppm) was 4:1 for bacterial suspensions and 6:1 for viral suspensions. The presence of saliva increased the minimum inhibitory volume ratio to 8:1 and 7:1 for bacteria and viruses, respectively. Applying a higher concentration of HOCl solution (220 or 330 ppm) did not lead to a significant decrease in the minimum inhibitory volume ratio against S. intermedius and P. micra. The minimum inhibitory volume ratio increases in applications of HOCl solution via the dental unit water line. One week of storage of HOCl solution degraded HOCl and increased the minimum growth inhibition volume ratio.

Conclusions

HOCl solution (45–60 ppm) is still effective against oral pathogens and SAR-CoV-2 surrogate viruses even in the presence of saliva and after passing through the dental unit water line. This study indicates that the HOCl solution can be used as therapeutic water or mouthwash and may ultimately reduce the risk of airborne infection in dental practice.

Peer Review reports

Introduction

Airborne infection is a long-standing problem yet to be solved in dental practice. The coronavirus disease of 2019 (COVID-19) pandemic underscores the importance of this issue and has increased interest in environmental disinfection measures. In the oral cavity, pathogens harbor in various sites, including saliva, mucous membranes, and tooth surfaces [1,2,3]. The oral cavity is also a harbor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, and viral particles have been detected in the saliva of COVID-19 patients [4, 5]. Most routine dental procedures generate aerosols from the use of rotary instruments, air syringe, or ultrasonic scaler, forced air, sonication, and water derived from contaminated dental unit water line (DUWL). These operations routinely produce a profusion of contaminated particles in a range of sizes that include both droplets (a size larger than 5 µm) and aerosols (a size smaller than 5 µm) [6], which are released into the air and spread pathogens [1, 2, 7, 8]. Indeed, 16 bacterial and 23 fungal species have been found in bio-aerosols in the dental environment [1]; the oral-derived aerosol is considered as a major route of infection transmission between patients and dental care providers [9]. In this context, several factors affect the risk of airborne infection, including such as the proximity to the source and the duration of exposure; combining these factors increases the risk [10]. The emission of contaminated particles is denser the closer they are to the source, the oral cavity. Aerosols are smaller/lighter than droplets, allowing them to remain airborne for extended periods of time, increasing the risk of infection [11, 12]. Sustained proximity to a patient during aerosol generating procedures exposes care providers to dense contaminated emissions and faces a high risk for infection. Furthermore, in poorly ventilated spaces, contaminated aerosols can accumulate, leading to a greater risk for infection [10, 13]. Personal protective equipment such as N-95 masks and environmental controls including dental dam, saliva ejector, high-volume evacuator, and general ventilation are risk mitigating factors reducing exposure to contaminated aerosols; however, dental health care providers are not fully protected from the risk by these measures as the spread of aerosols cannot be completely blocked [13, 14]. Therefore, inactivation of the pathogen prior to aerosol spread would be critical for effective prevention of airborne infection transmission.

Hypochlorous acid (HOCl) is a powerful oxidant that exerts its broad-spectrum microbicidal effect through inhibition of Adenosine 5ʹ-triphosphate synthesis, structure and replication of nucleic acids, protein synthesis, and cell wall synthesis [15,16,17]. To date, there have been numerous reports on the potent microbicidal activity and safety of HOCl in environmental disinfection and antisepsis [18,19,20]. In addition, the efficacy of topically applied HOCl in promoting wound healing and its mechanism of action has been reported [21,22,23]. Based on this evidence, HOCl solution is included in the World Health Organization (WHO) list of coronavirus-effective biocides and the US Environmental Protection Agency ‘N’ list of disinfecting agents able to control emerging pathogens, including SARS-CoV-2 [24, 25]. The US Food and Drug Administration has cleared aqueous HOCl formulations for topical use in wound management. In addition, inexpensive but reliable generators of HOCl solutions are commercially available. An ideal disinfectant should be nontoxic to humans, effective against a wide range of pathogens, and relatively inexpensive; HOCl meets all these requirements for disinfectants.

Taking the advantage of HOCl above, reliable decontamination of treatment-derived aerosols before their diffusion is an advanced and revolutionary concept that has never been achieved in dental infection control. To date, potential clinical applications of HOCl in the field of dentistry, such as mouthwash and water treatment of dental units, have been discussed [26, 27]. However, there is a lack of systematic basic data showing the efficacy of HOCl against oral pathogens. The present study aimed to evaluate the efficacy of HOCl against human oral pathogens and a SARS-CoV-2 surrogate, considering factors such as concentration, amount, time of application, presence of saliva, and DUWLs.

Materials and methods

Preparation of hypochlorous acid and microorganisms

Hypochlorous acid was generated by electrolysis of 3% hydrochloric acid using an Apia Mini generator (Hokuty Hokuetsu Co. Ltd., Kanagawa, Japan). Additional electrolysis cycles applied to obtain higher concentration HOCl solutions. HOCl solutions with 45–60 ppm total chlorine content were used in all assays unless otherwise specified. The total chlorine content was determined using the UHR chlorine photometer (HI96734) and Chlorine Ultra High Range Reagent Set (HI95771-01; both Hanna Instruments, Inc., Woonsocket, RI, USA). Stored-HOCl was prepared by placing fresh HOCl solution in a plastic bottle and allowing it to stand at room temperature for 1 week. The average total chlorine concentration of stored-HOCl was 26 ppm. HOCl solution passed through DUWL in use (DUWL-HOCl) was obtained at the University of Michigan Graduate Endodontics Clinic as follows. The operating dental unit water was replaced with HOCl solution in dental chairs at the Graduate Endodontics Clinic. After flushing the residual regular water out using a sterilized 3-in-1 syringe, HOCl sample dispensed from DUWL was collected and immediately used. Note that the dental chairs are regularly treated with Citrisil (daily) and Citrisil All-In-One (once a month; both Sterisil, Inc., Palmer Lake, CO, USA). Fusobacterium nucleatum (Fn; American Type Culture Collection (ATCC) 25,586, ATCC, Manassas, VA, USA), Prevotella intermedia (Pi; ATCC 25,611), Streptococcus intermedius (Si; ATCC 27,335), Parvimonas micra (Pm; ATCC 33,270) were grown on tryptone soy agar (TSA) plate with sheep blood (R01202, 5% Sheep Blood in Tryptic soy agar, Remel, Lenexa, KS, USA) in an anaerobic chamber (85% N2, 10% H2, and 5% CO2). Oxyrase (Oxyrase Inc., Mansfield, OH, USA) was used following the manufacturer's instructions in order to reduce the effect of atmospheric oxygen in the suspension preparation. The bacterial suspension was diluted by Oxyrase-PBS solution and adjusted to an optical density (OD) of 1.0 (1.0 × 109 cells/ml) in all bactericidal assays. OD was measured with a spectrophotometer (Thermo Fisher Scientific, Genesys 20, Rochester, NY, USA) with 600 nm wavelength. The bacterial suspensions were freshly prepared on a per-experiment basis.

Evaluation of HOCl efficacy on oral pathogens in vitro

The impact of usage, storage, residual chlorine content, organic matter, and supply route on the microbicidal activity of HOCl solution was evaluated as a change in the "minimum inhibitory volume ratio," which is how much HOCl solution volume is required to completely inactivate a suspension of pathogens. HOCl solution and bacterial suspensions (OD = 1) were mixed at various volume ratios (Range: 0.25: 1–16: 1 [HOCl: Bacteria by volume]) under ambient air. The mixtures were vortexed, and then chlorine was neutralized with 10 µl of 0.5% Sodium thiosulphate. The entire process took less than 30 s to avoid the influence of ambient oxygen as much as possible. Prepared samples (200 µl of each) were anaerobically cultured and triplicate samples were prepared per condition. Oxyrase-treated PBS (no HOCl solution) served as a control and applied to bacterial suspension in the same protocol.

In the experiment with stored-HOCl, Pi was used as the representative strain. To evaluate the effect of presence of saliva, commercially available human saliva (991-05-P, Lee Biosolutions, Maryland Heights, MO) was employed. Given possible bacteria in the saliva, the saliva was subjected to three freeze–thaw cycles prior to the experiment. After the freeze–thaw cycles, eradication of bacteria was confirmed by anaerobic culture of the saliva on TSA plate with sheep blood for 48 h. The saliva was mixed with Oxyrase, and Oxyrase-saliva was used for microbial suspensions instead of Oxyrase-PBS. The saliva itself used in this study was preliminarily confirmed to have no effect on bacterial growth.

Preparation of host cells and virus stock

Mouse hepatitis virus (ATCC VR-764 (MHV-A59)) was employed as a SARS-CoV-2 surrogate and propagated in NCTC clone 1469 cells (ATCC CCL-9.1) following ATCC’s instruction. In brief, NCTC clone 1469 cells were cultured in NTCT135 medium (NC1804122, Life Technologies, USA) containing 10% horse serum (H1270, MilliporeSigma, USA) at 37 °C with 5% CO2 and 100% relative humidity. Cultured NCTC cells were seeded in 96-well at 3.0 × 104 cells/ well as host cells. MHV-59 virus was diluted 1:100 in serum-free NCTC135 medium and inoculated into the host cells. After 1 h incubation, virus suspension was replaced with NTCT135 medium containing 2% horse serum [28]. The inoculated cells were cultured for 7 days, and the culture supernatants containing the virus were harvested, quickly frozen, and stored as viral stock in liquid nitrogen until use.

Viral titer was evaluated by endpoint dilution assay using NCTC clone 1469 cells. NTCT clone 1469 cells were seeded in 96-well plates with NCTC135 medium at 3.0 × 104 cells/well containing 10% horse serum and incubated for 24 h at 37 °C. The virus solution was diluted with NTCT 135 medium in serial tenfold dilution and used for inoculation. Cytopathogenic effect (CPE) scores were assessed by inverted phase contrast microscopy on the second day after inoculation. The virus titer (TCID50) was calculated using the method of Reed-Muench [29]. Virus stock solutions with a titer of 6.8 × 105 (TCID 50/ml, in a single lot) were used in all virucidal assays. The procedures of these bactericidal and virucidal assays were summarized in Fig. 1.

Fig. 1
figure 1

Schematic of the key steps in bactericidal and virucidal assays detailed in Materials and methods

Full size image

Evaluation of virucidal efficacy of HOCl solution

The virus stock was thawed in a 37 °C water bath. To determine the minimum inhibitory volume ratio for MHV-59 virus, the virus stock was mixed with HOCl solution at the various volume ratios for 30 s at room temperature. Then, effective chloride was neutralized with sodium thiosulfate as described above. The mixtures were diluted 1:100 in NTCT135 medium and inoculated to the host cells. The minimum volume ratio at which CPE was not observed was determined on day 2 after infection as described above. For the effect of saliva, saliva was pre-treated with a protease inhibitor (Halt™ protease inhibitor #1862209, Thermo Scientific) for 1 h at room temperature to reduce the negative effect of the protease on host cells. The volume ratio of saliva to virus suspension was pre-optimized to 9:1 because excess saliva inhibits the viral infection to host cells. A saliva-virus suspension was incubated for 10 min at room temperature. The saliva-virus suspension was treated with HOCl at various volume ratios as above. Sample dilution, inoculation, and CPE evaluation are described above.

Results

First, freshly prepared HOCl solutions (45–60 ppm chlorine content) were applied at various volume ratios to bacterial suspensions (1.0 × 109 cells/ml) in the absence of saliva to determine the minimum inhibition volume ratio (Table 1). The sensitivity of bacteria to HOCl solution tended to vary among the species, with Fn and Pi appearing to be more sensitive compared to Si and Pm. However, at the volume ratio of 4:1 (4 × HOCl solution to bacterial suspension), all species were completely inhibited within 30 s. Thus, the minimum inhibitory volume ratio for common human oral pathogens was 4:1.

Table 1 Effect of freshly prepared/stored HOCl solution at various mixing volume ratios on oral pathogens
Full size table

Using Pi as a representative specie, the effect of storage on the minimum inhibitory volume ratio was determined. One week storage of HOCl solution reduced the chlorine content from 46 to 26 ppm; the minimum inhibitory volume ratio of fresh HOCl solution to Pi was 2:1 but increased to 4:1 in the stored solution (Table 1).

Next, we examined whether high concentrations could decrease the minimum inhibitory volume ratio. In this experiment, high concentrations of HOCl solution applied to the bacterial suspension at a 2:1 volume ratio, which is smaller than the minimum inhibitory volume ratio for common oral pathogens above. As shown in Table 2, high concentrations of HOCl were as effective as medium concentrations of HOCl for Fn and Pi (Table 1), but even the highest concentrations did not reduce the minimum inhibitory volume ratio of Si and Pm.

Table 2 Bactericidal effect of HOCl solution at high chlorine concentrations
Full size table

Saliva has a non-negligible effect on oral disinfection. Saliva contains various organic substances, which reduce the bactericidal effect of HOCl. Thus, we examined the extent to which saliva reduced the bactericidal effect of HOCl. In the presence of saliva, the minimum inhibitory volume ratio for common oral pathogens increased to 8:1 from 4:1 (Table 3).

Table 3 Bactericidal activity of fresh-HOCl solution in the presence of saliva
Full size table

Besides bacteria, the virucidal efficacy of a medium concentration of HOCl solution was examined using MHV-A59, a surrogate virus for SAR-CoV-2. In the absence of saliva, the minimum inhibitory volume ratio for the surrogate virus was 6:1; in the presence of saliva, the minimum inhibitory volume ratio for the surrogate virus increased to 7:1 (Table 4).

Table 4 Viricidal effect of HOCl solution on MHV-A59
Full size table

In dental practice, water is supplied through the DUWLs. Therefore, we investigated the disinfection effect of HOCl solution after passing through the DUWL. Before testing the disinfection effect, we confirmed the contamination level of the DUWL in our clinic. No heterotrophic bacteria were detected in one unit, while a maximum 25 colony-forming units (CFU)/ml of bacteria were found in the other unit. This was within the Centers for Disease Control and Prevention/Americans with Disabilities Act DUWL water quality guidelines of < 500 CFU/ml. The level of DUWL contamination was ignorable. The HOCl solution dispensed from the 3-way syringe after passing through the DUWL (DUWL-HOCl) required 8 times volume ratio to achieve sufficient antimicrobial effect. There was no difference in the amount of DUWL-HOCl required for bactericidal effect with or without saliva (Table 5).

Table 5 Bactericidal effect of HOCl solution passed through the DUWL
Full size table

Discussion

The efficacy of HOCl solution against pathogens is affected by many factors, including pH, chlorine concentration, and application method (duration of action, volume, and type of pathogen) [16, 30, 31]. It has been shown that increasing the volume, residual chlorine concentration, and treatment time of HOCl leads to improved microbicidal activity [32, 33]. In this study, we focused on the impact of usage, residual chlorine content, organic matter, supply route, and storage on the microbicidal activity of HOCl solution. In addition, the influence of saliva (an organic matter-rich body fluid) and the DUWL, which are specific to dental treatment, was examined. The duration of action of HOCl was fixed within 30 s in all assays, taking into account the effect of atmospheric oxygen on the strict anaerobes. Therefore, the duration effect on the microbicidal effect was not considered in this study. MHV-A59 was used as a substitute for SARS-CoV-2 in this study, since a BSL-3 lab is required for handling SARS-CoV-2. The adequacy of MHV-A59 as a substitute for SARS-CoV-2 has been previously shown [34, 35]. The efficacy of HOCl solutions against various viruses [36,37,38,39,40], including SARS-CoV-2 [41], has been confirmed in previous studies, and thus resistance of SARS-CoV-2 to HOCl solution may not be a major concern. However, we needed to assess the inhibition of HOCl efficacy by saliva.

Under the condition of a medium concentration of HOCl (45–60 ppm) and 30 s of duration, the bactericidal effect of HOCl solution was dose-dependent and completely inactivated all pathogens at a minimum inhibitory volume ratio 6:1 to microbial suspensions in the absence of saliva. Regarding bacteria, Si and Pm, both Gram-positive species, required higher volumes of HOCl solution than Gram negative Fn and Pi.

Increasing the volume of medium-concentration HOCl solution led to more effective microbicidal activity than the use of small volumes of high-concentration solution. This result may be related to the acidity-dependent activity of HOCl. High concentrations of HOCl solution were achieved by multiple cycles of 3% hydrochloric acid electrolysis. As a result, high concentration HOCl solutions were more acidic. The medium concentration HOCl solutions (45–60 ppm total chlorine content) used in most of this study exhibit a pH of about 4, whereas high concentration solution (about 400 ppm total chlorine content) was highly acidic with a pH of 1–2 (data not shown). It is known that HOCl chlorine species, the most oxidizing chlorine species in HOCl solutions, drastically decreases along with acidity when the pH is less than 3.5 [42, 43], and its bactericidal effect decreases. Therefore, in the use of a HOCl solution, the acidity as well as the concentration should be taken into consideration.

The presence of organic matter-rich saliva in the oral cavity is a characteristic disruptive factor for the efficacy of HOCl solution as disinfectant because organic compounds such as proteins consume HOCl chlorine species rapidly by oxidation reactions [44]. Even in the presence of saliva, all tested microorganisms were inactivated within 30 s by using at least 8 times the volume of HOCl solution, although the minimum growth inhibition volume ratio depended on the type of pathogen. Here, let us consider this minimum inhibitory volume ratio of 8:1 in conjunction with the oral situation. Saliva contains an average of 1.0 × 108 bacteria/ml [45], a lower concentration than the bacterial suspension used in this study. The mean volume of residual saliva is 0.77 ml (range 0.38–1.73 ml) in the mouth [46] and a comfortable mouthwash volume on average is 15.0 ml [47]. The volume ratio of this residual saliva to mouthwash was 1:20, well above the minimum inhibitory volume ratio of 8:1. Thus, using a 15 ml medium concentration of HOCl solution as a mouthwash to effectively disinfect the oral cavity within 30 s seems to be a feasible approach.

A characteristic feature of dental practice is that water is supplied through long DUWL. The reduction of effective chlorine species by passing through the DUWL may be affected by the contamination level in the line. The treatment of DUWLs in the University of Michigan Graduate Endodontics Clinic maintained a low level of contamination, so the effect of the passage through DUWL on the minimum inhibitory volume ratio was very small (Table 5). Continuous use of HOCl solution may secondarily prevent contamination of the DUWL at the same time, but the need for treatment to clean up DUWL, such as Shock treatment, would be a matter of consideration. Storage is also an important factor that can decrease the residual chlorine content [16, 44]. The minimum inhibitory volume ratio increased after one week of storage at room temperature as shown in Table 1. Therefore, HOCl solutions must be prepared on demand or utilized within the shortest storage period possible.

Our in vitro research demonstrates that the HOCl solution has properties suitable for disinfection. However, the total residual chlorine content alone is not an indicator of the disinfection effect of the HOCl solution; the acidity and the volume of HOCl solution used should be considered simultaneously for optimal conditions. In addition, clinical studies of HOCl solution, including evaluation of patient acceptance, usability, and validation of the microbicidal effect in actual treatments, are essential for its clinical application.

Conclusion

The HOCl solution, used at optimal concentrations and amounts under experimental conditions with dental clinical considerations, completely inactivated the human oral pathogen and the SARS-CoV-2 surrogate virus in less than 30 s. Most likely, the use of HOCl solution will directly prevent the contamination of the aerosol and droplets. Although some issues remain for its clinical application, the use of HOCl solutions in the treatment water in dentistry and mouthwash could be a promising solution to the long-standing unsolved problem of reducing the risk of airborne infection in dental treatment.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

COVID-19:

Coronavirus disease of 2019

SARS-CoV-2:

Severe acute respiratory syndrome coronavirus 2

DUWLs:

Dental unit waterlines

HOCl:

Hypochlorous acid

WHO:

World Health Organization

Fn:

Fusobacterium nucleatum

Pi:

Prevotella intermedia

Si:

Streptococcus intermedius

Pm:

Parvimonas micra

TSA:

Tryptone soy agar

OD:

Optical density

CPE:

Cytopathogenic effect

CFU:

Colony for unit

References

  1. Zemouri C, de Soet H, Crielaard W, Laheij A. A scoping review on bio-aerosols in healthcare and the dental environment. PLoS ONE. 2017;12: e0178007.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Harrel SK, Molinari J. Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc. 2004;135:429–37.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zaura E, Nicu EA, Krom BP, Keijser BJF. Acquiring and maintaining a normal oral microbiome: current perspective. Front Cell Infect Microbiol. 2014;4:85.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huang N, Pérez P, Kato T, Mikami Y, Okuda K, Gilmore RC, et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27:892–903.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Teo AKJ, Choudhury Y, Tan IB, Cher CY, Chew SH, Wan ZY, et al. Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection. Sci Rep. 2021;11:3134.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Randall K, Ewing ET, Marr LC, Jimenez JL, Bourouiba L. How did we get here: what are droplets and aerosols and how far do they go? A historical perspective on the transmission of respiratory infectious diseases. Interface Focus. 2021;11:20210049.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Veena HR, Mahantesha S, Joseph PA, Patil SR, Patil SH. Dissemination of aerosol and splatter during ultrasonic scaling: a pilot study. J Infect Public Health. 2015;8:260–5.

    Article  PubMed  Google Scholar 

  8. Spagnolo AM, Sartini M, Cristina ML. Microbial contamination of dental unit waterlines and potential risk of infection: a narrative review. Pathogens. 2020;9:651.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Laheij AMGA, Kistler JO, Belibasakis GN, Välimaa H, de Soet JJ, European Oral Microbiology Workshop (EOMW) 2011. Healthcare-associated viral and bacterial infections in dentistry. J Oral Microbiol. 2012. https://doi.org/10.3402/jom.v4i0.17659.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Klompas M, Baker M, Rhee C. What is an aerosol-generating procedure? JAMA Surg. 2021;156:113–4.

    Article  PubMed  Google Scholar 

  11. Miller RL, Micik RE, Abel C, Ryge G. Studies on dental aerobiology. II. Microbial splatter discharged from the oral cavity of dental patients. J Dent Res. 1971;50:621–5.

    Article  PubMed  Google Scholar 

  12. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res. 2020;188: 109819.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rexhepi I, Mangifesta R, Santilli M, Guri S, Di Carlo P, D’Addazio G, et al. Effects of natural ventilation and saliva standard ejectors during the COVID-19 pandemic: a quantitative analysis of aerosol produced during dental procedures. Int J Environ Res Public Health. 2021;18:7472.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kumbargere Nagraj S, Eachempati P, Paisi M, Nasser M, Sivaramakrishnan G, Verbeek JH. Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases. Cochrane Database Syst Rev. 2020;10:CD013686.

    PubMed  Google Scholar 

  15. Kiamco MM, Zmuda HM, Mohamed A, Call DR, Raval YS, Patel R, et al. Hypochlorous-acid-generating electrochemical scaffold for treatment of wound biofilms. Sci Rep. 2019;9:2683.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Block MS, Rowan BG. Hypochlorous acid: a review. J Oral Maxillofac Surg. 2020;78:1461–6.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hawkins CL, Davies MJ. Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol. 2002;15:83–92.

    Article  PubMed  Google Scholar 

  18. Nguyen K, Bui D, Hashemi M, Hocking DM, Mendis P, Strugnell RA, et al. The potential use of hypochlorous acid and a smart prefabricated sanitising chamber to reduce occupation-related COVID-19 exposure. Risk Manag Healthc Policy. 2021;14:247–52.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Thorn RMS, Lee SWH, Robinson GM, Greenman J, Reynolds DM. Electrochemically activated solutions: evidence for antimicrobial efficacy and applications in healthcare environments. Eur J Clin Microbiol Infect Dis. 2012;31:641–53.

    Article  PubMed  Google Scholar 

  20. Day A, Alkhalil A, Carney BC, Hoffman HN, Moffatt LT, Shupp JW. Disruption of biofilms and neutralization of bacteria using hypochlorous acid solution: an in vivo and in vitro evaluation. Adv Skin Wound Care. 2017;30:543–51.

    Article  PubMed  Google Scholar 

  21. Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous acid: an ideal wound care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26:342–50.

    PubMed  Google Scholar 

  22. Mekkawy MM, Kamal A. A randomized clinical trial: the efficacy of hypochlorous acid on septic traumatic wound. J Educ Pract. 2014;5:89–100.

    Google Scholar 

  23. Pandey P, Koushariya M, Shukla SG, Das S. Outcomes of superoxide solution dressings in surgical wounds: a randomized case control trial. Int J Biol Med Res. 2011;2:965–8.

    Google Scholar 

  24. World Health Organization. Cleaning and disinfection of environmental surfaces in the context of COVID-19. 2020. Available from: https://www.who.int/publications/i/item/cleaning-and-disinfection-of-environmental-surfaces-inthe-context-of-covid-19. Accessed 23 Dec 2022.

  25. United State Environmental Protection Agency. About list N: disinfectants for coronavirus (COVID-19). 2022. https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2. Accessed 23 Dec 2022.

  26. Lafaurie GI, Zaror C, Díaz-Báez D, Castillo DM, De Ávila J, Trujillo TG, et al. Evaluation of substantivity of hypochlorous acid as an antiplaque agent: a randomized controlled trial. Int J Dent Hyg. 2018;16:527–34.

    Article  PubMed  Google Scholar 

  27. Shajahan IF, Kandaswamy D, Srikanth P, Narayana LL, Selvarajan R. Dental unit waterlines disinfection using hypochlorous acid-based disinfectant. J Conserv Dent. 2016;19:347–50.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Leibowitz J, Kaufman G, Liu P. Coronaviruses: propagation, quantification, storage, and construction of recombinant mouse hepatitis virus. Curr Protoc Microbiol. 2011; Chapter 15:Unit 15E.1.

  29. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:493–7.

    Article  Google Scholar 

  30. Yan P, Daliri EB, Oh D. New clinical applications of electrolyzed water: a review. Microorganisms. 2021;9:136.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ampiaw RE, Yaqub M, Lee W. Electrolyzed water as a disinfectant: a systematic review of factors affecting the production and efficiency of hypochlorous acid. J Water Process Eng. 2021;43: 102228.

    Article  Google Scholar 

  32. Chen C, Chen C, Ding S. Effectiveness of hypochlorous acid to reduce the biofilms on titanium alloy surfaces in vitro. Int J Mol Sci. 2016;17:1161.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Boecker D, Breves R, Zhang Z, Bulitta C. Antimicrobial activity in the gasphase with hypochloric acid. Curr Dir Biomed Eng. 2021;7:511–4.

    Article  Google Scholar 

  34. Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of mice and men: the coronavirus mhv and mouse models as a translational approach to understand SARS-CoV-2. Viruses. 2020;12:880.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ahmed W, Bertsch PM, Bibby K, Haramoto E, Hewitt J, Huygens F, et al. Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology. Environ Res. 2020;191: 110092.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Taharaguchi M, Takimoto K, Zamoto-Niikura A, Yamada YK. Effect of weak acid hypochlorous solution on selected viruses and bacteria of laboratory rodents. Exp Anim. 2014;63:141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hakim H, Thammakarn C, Suguro A, Ishida Y, Kawamura A, Tamura M, et al. Evaluation of sprayed hypochlorous acid solutions for their virucidal activity against avian influenza virus through in vitro experiments. J Vet Med Sci. 2015;77:211–5.

    Article  PubMed  Google Scholar 

  38. Kim HJ, Lee J, Kang JW, Cho H, Kim HS, Byeon HK, et al. Effects of a low concentration hypochlorous Acid nasal irrigation solution on bacteria, fungi, and virus. Laryngoscope. 2008;118:1862–7.

    Article  PubMed  Google Scholar 

  39. Tamaki S, Bui VN, Ngo LH, Ogawa H, Imai K. Virucidal effect of acidic electrolyzed water and neutral electrolyzed water on avian influenza viruses. Arch Virol. 2014;159:405–12.

    Article  PubMed  Google Scholar 

  40. Park GW, Boston DM, Kase JA, Sampson MN, Sobsey MD. Evaluation of liquid- and fog-based application of Sterilox hypochlorous acid solution for surface inactivation of human norovirus. Appl Environ Microbiol. 2007;73:4463–8.

    Article  PubMed  PubMed Central  Google Scholar 

  41. National Institute of Technology and Evaluation. Final report on efficacy assessment of disinfecting substances alternative to alcohol for use against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 2020. Available from: https://www.nite.go.jp/en/nbrc/sarscov2_finalreport.html. Accessed 23 Dec 2022.

  42. Wang L, Bassiri M, Najafi R, Najafi K, Yang J, Khosrovi B, et al. Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007;6:e5.

    PubMed  PubMed Central  Google Scholar 

  43. World Health Organization. Hypochlorous Acid (HOCl) for disinfection, antisepsis, and wound care in Core Categories 15.1, 15.2, and 13. Nov 2020. Available from: https://cdn.who.int/media/docs/default-source/essential-medicines/2021-eml-expert-committee/applications-for-addition-of-new-medicines/a.18_hypochlorous-acid.pdf?sfvrsn=35222172_4. Accessed 23 Dec 2022.

  44. Ishihara M, Murakami K, Fukuda K, Nakamura S, Kuwabara M, Hattori H, et al. Stability of weakly acidic hypochlorous acid solution with microbicidal activity. Biocontrol Sci. 2017;22:223–7.

    Article  PubMed  Google Scholar 

  45. Lynge Pedersen AM, Belstrøm D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019;80(Suppl 1):S3–12.

    Article  PubMed  Google Scholar 

  46. Lagerlöf F, Dawes C. The volume of saliva in the mouth before and after swallowing. J Dent Res. 1984;63:618–21.

    Article  PubMed  Google Scholar 

  47. Keukenmeester RS, Slot DE, Rosema NAM, Van der Weijden GA. Determination of a comfortable volume of mouthwash for rinsing. Int J Dent Hyg. 2012;10:169–74.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr. Nobuyuki Kawashima of Tokyo Medical and Dental University for his assistance in the acquisition of the equipment, and Drs. Tatiana Botero, Romesh P. Nalliah, and Kenichi Kuroda (all University of Michigan School of Dentistry) for insightful discussions. We thank the members of the Division of Endodontics, University of Michigan School of Dentistry, for their assistance in this study.

Funding

The study was supported in part by the National Institute of Dental and Craniofacial Research/National Institutes of Health under awards R01DE024796 and R56DE024796 (H.S.) and University of Michigan LeGro research award (R.J).

Author information

Authors and Affiliations

  1. Department of Cariology, Restorative Sciences, and Endodontics, School of Dentistry, University of Michigan, 1011 N University Ave, Ann Arbor, MI, 48109, USA

    Kento Tazawa, Rutuja Jadhav, Mariane Maffei Azuma, Neville J. McDonald & Hajime Sasaki

  2. Division of Oral Health Sciences, Department of Pulp Biology and Endodontics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    Kento Tazawa

  3. Department of Biologic and Materials Sciences & Prosthodontics, School of Dentistry, University of Michigan, Ann Arbor, MI, 48109, USA

    J. Christopher Fenno

Authors
  1. Kento Tazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rutuja Jadhav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mariane Maffei Azuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Christopher Fenno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Neville J. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hajime Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HS: Conceptualization, Funding acquisition, Methodology, Resources, Writing - Review & Editing, Project administration; KT: Methodology, Investigation, Formal analysis, Validation, Visualization, Writing – Original Draft; RJ: Funding acquisition, Methodology, Investigation, Formal analysis, Validation, Visualization; MMA: Methodology; NJM: Resources, Writing - Review & Editing; JCF: Resources, Writing - Review & Editing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hajime Sasaki.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tazawa, K., Jadhav, R., Azuma, M.M. et al. Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate. BMC Oral Health 23, 111 (2023). https://doi.org/10.1186/s12903-023-02820-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-023-02820-7

Keywords

BMC Oral Health

ISSN: 1472-6831

Contact us